Cyclic adenosine monophosphate (cAMP) is an important second messenger mediating physiological functions, including metabolism, gene expression, cell growth and differentiation. Recently, we demonstrated novel roles of cAMP pathway in endothelial cell (EC) differentiation and arterial - venous specification using an embryonic stem cell differentiation system. These studies offered a concept that vascular formation is accomplished by a 2-layered mechanism: (1) a basal mechanism for common EC differentiation, whereby vascular endothelial growth factor (VEGF) signaling plays a central role in the basal mechanism, and (2) a vascular diversification mechanism working on the basis of common EC differentiation. Vascular diversification, such as artery and vein formation, can be only achieved by enacting specific machineries in the presence of the basal EC machinery. cAMP/protein kinase A signaling contributes to common EC differentiation through upregulation of the VEGF-A receptors, Flk1 and neuropilin1. On the other hand, cAMP can activate phosphatidylinositol-3 kinase, which induces an arterial fate in vascular progenitors via dual activation of Notch and β-catenin signaling as an arterial-specific machinery. cAMP signaling thus plays a pivotal role in both the basal and diversification machinery during vascular development. (Circ J 2011; 75: 253 - 260) 
yclic adenosine monophosphate (cAMP) discovered in the late 1950s marked the birth of the second messenger theory and sparked signal transduction research. 1 Adenylate cyclase generates cAMP from ATP in essentially all tissues in the body. This enzyme is embedded in the plasma membrane and is activated by transmembrane receptors that are coupled to trimeric G-proteins. 2, 3 The effects of cAMP are mediated by various downstream targets, such as protein kinase A (PKA), and exchange protein directly activated by cAMP (Epac). 4 PKA and Epac contain an evolutionally conserved cAMP-binding domain that acts as a molecular switch for sensing intracellular second messenger cAMP levels to control diverse biological functions. 4 At the cellular level, cAMP plays an important role in almost every known physiological action, such as metabolism, gene expression, cell division and growth, cell differentiation and apoptosis, as well as secretion and neurotransmission.
In cardiovascular biology, cAMP is a critical second messenger in the modulation of vasodilation, cardiac chronotropic and inotropic responses, cellular growth, and hypertrophy. 5 For example, cAMP/PKA signaling potently inhibits smooth muscle cell (SMC) proliferation and migration. Increased levels of cAMP markedly inhibit SMC proliferation by arresting the cells primarily in the G1 and G2/M phases of the cell cycle. 6 Furthermore, cAMP-elevating G protein-coupled receptor (GPCR) agonists, including adrenomedullin (AM), prostacyclin, prostaglandin E2 (PGE2), and β-adrenergic agonists, reduce endothelial permeability. 7,8 cAMP/Epac signaling enhances the vascular barrier property that stabilizes the VE -cadherin-mediated cell -cell adhesion and inhibits permeability. 9 Although cAMP-mediated signaling pathways regulate a multitude of important vascular functions under physiological conditions, the role of cAMP in vascular development is still unclear.
Until now, most studies of vascular development have consisted of gene knockout and gene inhibitory studies using mice and zebrafish. Although these studies led to the discoveries of essential factors in vascular development, they could not sufficiently identify the conditions required for vascular formation. To clarify the "constructive" mechanisms underlying vascular development, we have developed a novel embryonic stem (ES) cell differentiation system, which exhibits early vascular development using VEGFR2 (Flk1) -positive cells as common progenitors for vascular cells (Figure 1 ). 10, 11 Using this system, we can systematically induce vascular cells in vitro and dissect their differentiating processes in detail. We
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recently demonstrated that cAMP signaling plays a critical role in the reconstitution of endothelial cells (ECs) and arterial specification in vascular development. 12, 13 In this review, we focus on the molecular mechanisms of vascular development/differentiation and diversification from vascular progenitors.
Molecular Mechanisms of EC Differentiation

Roles of VEGF Signaling in Vascular Development
Numerous vascular formation factors, such as vascular endothelial growth factors (VEGF), neuropilin (NRP), angiopoietins, transforming growth factor-β, platelet-derived growth factor, fibroblast growth factor, ephrin, and Notch, have been identified within the past few decades. Among these factors, VEGF/Flk1 signaling plays the most important role in the production of vascular progenitors and EC differentiation. 14 Lateral plate mesoderm expresses Flk1, and migrates into the extra-embryonic yolk sac to form a vascular capillary plexus, leading to the development of a functional circulatory system. 15 Flk1 null mice die at E8.5 -E9.5, without organized blood vessels. 16 Heterozygous VEGF-A null mice die in early gestation due to failure in vascular system formation. 17 On the other hand, two-to threefold overexpression of VEGF-A from its endogenous locus results in aberrant heart development and lethality at E12.5 -E14, 18 indicating that strictly balanced VEGF function is important in normal embryogenesis.
NRP1 acts as another VEGF-A receptor in blood vessels and endocardial cells of the heart. 19,20 NRP1 is also expressed in particular classes of developing neurons, 21,22 and functions as a receptor for the class 3 semaphorins that mediate semaphorin-elicited inhibitory axon guidance signals to neurons. 23,24 NRP1, together with Flk1, forms a specific receptor for VEGF-A165, an isoform of VEGF, and the Flk1-VEGF-A165 -NRP1 complex potently enhances Flk1 signaling. 20 NRP1 null mice die midway through gestation at E10.5 -E12.5 and exhibit defects of the heart, vasculature, and nervous system, 22 indicating that the relationship between VEGF165 and NRP1 is critical in vascular development.
Growth factors and hypoxia are known to induce VEGF-A gene expression. Hypoxia-inducible factor (HIF) markedly produces VEGF and contributes to formation of the vascu- 
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lar tube in embryogenesis as well as in adults. Null mice for HIF1a, HIF2a, and HIF-related genes have vascular defects and die at E9.5 -E10.5, 25 indicating that HIF-related VEGF production regulates vascular development. However, the mechanisms that regulate the expression of the VEGF receptors, Flk1 and NRP1, in vascular development are not fully elucidated.
Roles of cAMP/PKA Signaling in Vascular Development
We have previously shown that cAMP signaling enhances EC differentiation, using an ES cell differentiation system. 26 We further investigated the molecular mechanisms of cAMP in EC differentiation, and we recently showed that activation of cAMP/PKA signaling increased the VEGF receptors, Flk1 and NRP1, but not the VEGF ligand. Furthermore, the cAMP/PKA pathway markedly formed the protein complex of Flk1 -VEGF-A165 -NRP1, and enhanced the sensitivity of the progenitors to VEGF165 by more than 10-fold (Figure 2) . 12 These results indicate that PKA regulates "progenitor sensitivity" in EC differentiation by changing the characters of the vascular progenitors, not by producing growth factors. NRP1 was largely co-expressed with Flk1 in vascular progenitors derived from human and mouse ES cells. 27 These 2 functional markers for vascular progenitors might be commonly regulated by PKA to efficiently enhance their progenitor potential of responding to VEGF signaling.
Various factors, such as AM, 7 PGI, PGE2, 8 adiponectin, 28 ghrelin, 29 klotho, and mechanical stress, especially fluid shear stress, 30 have been reported to activate the cAMP/PKA pathway in ECs. Our previous studies showed that AM enhanced the VEGF-induced EC differentiation from Flk1 + vascular progenitors. 26 AM knockout mice demonstrated defective vascular formation and did not survive beyond mid gestation, 31 indicating that AM is a one of the key factors regulating the cAMP/PKA pathway in vascular development. However, the main role of cAMP production in vascular development is not yet clearly understood.
Molecular Machinery of Arterial-Venous Specification
Mechanisms of Artery Formation Molecular differences between arterial and venous ECs become apparent before circulation begins. 32- 34 The first genes for arterial -venous specification to be identified were ephrinB2 and EphB4. These members of the Eph -ephrin family were discovered to be differentially expressed in the endothelium of arteries and veins, even before the onset of blood flow and heart beat. 32, 33 Since then, various other arterialvenous markers have been identified. Arterial ECs are known to express Notch pathway molecules, 35,36 such as Notch1, Notch4, Dll4, and Jagged1, NRP1, 37 the chemokine receptor CXCR4, 26,38,39 the gap junction protein connexin-37 and connexin-40, CD44, Bmx, and activin receptor-like kinase 1 (Alk1) (Figure 3) . 37 Recent accumulated evidence concerning the roles of the Eph -ephrin, Unc -Netrin, and NRPplexin -semaphorin families suggests that blood vessels and nerves share a similar molecular machinery to form their networks, and that these molecules are associated with arterialvenous specification and intersomitic vessel guidance. 40 
Roles of Notch Signaling in Artery Formation
A variety of evidence from mammals has highlighted the importance of Notch signaling in the proper formation of the vasculature. In ECs, Notch (Notch1, 4) activation can be induced by various Notch ligands, including Dll1, Dll4, and Jagged2, expressed in arterial ECs, and Jagged1 expressed in ECs and mural cells. 35, 36 All of this Notch signaling is considered to be mediated by the Notch intracellular domain (NICD) and RBP-J transcription factor (also called CSL, CBF-1 in mammals, Suppressor of Hairless [Su(H)] in Drosophila and LAG-1 in Caenorhabditis elegans). Genetic animal studies of the Notch signal related-genes have shown that Notch1 and 4, Dll4, RBP-J, and Hey1/Hey2 are essential for arterial formation in the developing vasculature. 41- 45 However, EC-specific NICD transgenic mice partially induce arterial EC formation. 46 Moreover, Notch activation, together with VEGF stimulation Figure 3 . Arterial -venous specification markers in vascular formation. Arterial endothelial cells (ECs) are known to express ephrinB2, and Notch pathway molecules, such as Notch1, Notch4, Dll4, and Jagged1, neuropilin (NRP) 1, the chemokine receptor CXCR4, the gap junction protein connexin-37, connexin-40, CD44, Alk1, and Bmx. Venous ECs are known to express EphB4, NRP2, COUP-TFII, and the Apj receptor.
cAMP Signaling Regulates Vascular Development in Flk1 + cells, fails to induce arterial ECs in vitro, 26 indicating that Notch signaling is essential, but not sufficient, for arterial EC induction, suggesting that other factors are involved in this process.
Roles of Convergence Signaling of NOTCH and β-Catenin in Artery Formation
Wnt/ β-catenin signaling plays a key role in vascular biology. 47 Mice deficient for Wnt2 displayed vascular abnormalities, including defective placental vasculature. 48 Wnt receptor gene, Frizzled-5 knockout mice died in utero owing to defects in yolk sac angiogenesis. 49 Defects of the β-catenin gene in ECs caused a defective vascular pattern and increased vascular fragility. 50 We previously revealed that simultaneous activation of VEGF and cAMP in Flk1 + vascular progenitors leads to the induction of arterial ECs in vitro. We recently demonstrated a novel arterial specification machinery regulated by Notch and β-catenin signaling. 13 Both Notch and GSK3β-mediated β-catenin signaling were activated downstream of cAMP through phosphatidylinositol-3 kinase. Forced activation of Notch and β-catenin synergistically enhanced expression of the arterial markers, ephrinB2 and CXCR4. Interestingly, a protein complex with RBP-J, NICD, and β-catenin was formed on RBP-J binding sites of arterial genes in arterial, but not venous, ECs. Thus, the formation of the protein complex on arterial genes induced by cAMP activation could be the central machinery for arterial EC specification. These findings lead to an integrated and more comprehensive understanding of vascular signaling (Figure 4) . 13 Furthermore, the Notch -β-catenin -RBP-J complex suppresses differentiation of neural precursor cells, 51 indicating that the protein complex that directly converges Notch and β-catenin signaling may play a critical role in cell fate determination in various organs.
Beta-catenin signaling in ECs can be activated through Wnt ligands as well as by VE-cadherin. Thus, Wnt ligands such as Wnt2, 5a, and 10b, expressed in fetal blood vessels, are involved in EC differentiation. 47,48 VE-cadherin is heavily tyrosine phosphorylated and is linked to β-catenin. 52 When adherens junctions mature, the tyrosine residues in VE-cadherin tend to be dephosphorylated and β-catenin is partially released from the complex, 53 allowing nuclear translocation of β-catenin and activation of downstream signaling cascades. As VE-cadherin and β-catenin are broadly expressed in ECs, and mice with EC-specific disruption of β-catenin show broad vascular phenotypes, 50 β-catenin should have both a com- 
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mon role in ECs and a specific role in arterial ECs. A recent study showing that EC-specific β-catenin transgenic mice had enhanced Notch signaling and induced artery formation, also indicated that β-catenin signaling plays an important role in arterial EC specification. 54
Mechanisms of Vein Formation
Venous ECs are known to express EphB4, 32,55 NRP2, 37 COUP-TFII, 56 and the Apj receptor 57 (Figure 3) . The vein was considered to be the default character in vascular development. However, You et al reported that the chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) acts as an inducer of venous EC specification. 56 COUP-TFII establishes venous identity by suppressing arterial fate through downregulating Notch signaling. Other mechanisms involved in venous specification are still largely unknown.
Environmental Factors and Plasticity of Arterial-Venous Specification
Although the molecular pathways for arterial -venous specification is now becoming clear, we cannot ignore the involvement of physical factors such as flow shear stress. Chick embryo studies have shown that hemodynamic forces can alter EC identity after the onset of circulation. Ligation of specific arteries in the avian embryo can result in a reversible switch from arterial-specific markers, such as ephrinB2 and NRP1, to venous markers such as EphB4. 58 Furthermore, vascular progenitors or early ECs determined the arterialvenous specification by environmental conditions in a quail chick model. That is, the dorsal aorta, carotid artery and the cardinal and jugular veins were isolated with the vessel wall from quail embryos and grafted into the coelom of chick hosts. Early ECs, arterial ECs and venous ECs, can populate both artery and vein in host embryos and assume the appropriate molecular identity in their new locales, 59 indicating that even after the acquisition of arterial or venous identity the endothelium during vascular development remains plastic for arterial -venous differentiation. We also revealed that ECs derived from ES cells and at the early differentiation stage possess plasticity for arterial -venous specification. 13 Activation of Notch and β-catenin signaling in venous ECs derived from ES cells induced ephrinB2-positive arterial ECs. When activation of Notch and β-catenin signaling ceased in arterial ECs, ephrinB2 expression was attenuated and disappeared. Early arterial or venous ECs thus possess plasticity between the arterial and venous identities by the on/off of Notch and β-catenin signaling. 13 This evidence suggests that ECs in the early developmental stage are still plastic, and acquire their diverse identities from physical and environmental factors, as well as genetic factors, which leads to the formation of an elaborate and complex vascular network in the body. 
cAMP Signaling Regulates Vascular Development
Conclusion
Blood vessels are involved in the formation of most organs during ontogenesis, and they maintain homeostasis in the body. They have an abundance of diversification and play a specific role in respective organs. Our 2 recent studies of cAMP signaling in EC differentiation and other previous works present the concept that vascular formation in embryogenesis has 2 main mechanisms: (1) basal EC differentiation, and (2) vascular diversification in the context of ECs. cAMP signaling has the pivotal abilities of enhancing common EC differentiation through upregulation of Flk1 and NRP1, and determining the fate of arterial EC through dual activation of Notch and β-catenin signaling ( Figure 5 ). These findings, however, only partially explain the vascular developmental processes in the body. How is vascular branching determined in vascular development? How are specific blood vessels formed, such as the blood -brain barrier and the bloodplacenta barrier? A more detailed investigation into the local environment of ECs, such as interaction between SMCs, pericytes, bloods, and nerves, may lead to a more profound understanding of vascular diversity. Elucidation of all the cellular and molecular machinery of vascular formation will lead to a better understanding of various pathophysiologies, as well as ontogenesis/regeneration, and provide novel strategies for new drugs and future medical therapies.
